Navigation Links
GSK Seeks Permission to Market Breast Cancer Pill Tykerb

GlaxoSmithKline PLC has filed for permission with European medicine regulators to begin selling its new breast cancer pill Tykerb//.

This follows a similar move in the US last month, and comes slightly earlier than some commentators were expecting.

The drug is foreseen to be one of GSK's most promising pipeline drugs as well as a potential blockbuster. According to analysts at Nomura Code the sales of the drug could cross 2 bln used by 2010.

GSK, Europe's biggest pharmaceutical company has given an application for a license to market the drug as a treatment for advanced breast cancer wherein cancer has spread to other parts of the body. It is to be taken in combination with the chemotherapy agent Xeloda, made by Roche Holdings AG.

Possible candidates for the treatment are women who failed to respond to Roche's and Genentech Inc's drug Herceptin.

While Tykerb is taken daily in a pill form, Herceptin is given as injections every month.

Clinical trials showed a longer time to disease progression among women taking Tykerb, almost double that seen among those receiving e chemotherapy agent alone.

Positive results caused an early end to the trial.

According to GSK over 360,000 new cases of breast cancer are diagnosed every year in Europe, and around half of those women will go on to develop advanced, or metastatic disease.
NLA
'"/>




Page: 1

Related medicine news :

1. Gujarat Seeks To Scale Down Infant Mortality Rate
2. Europe Seeks Indian Expertise
3. Book Seeks To Rehabilitate Soldiers
4. Government Seeks To Wipe Out Prostitution
5. Multiple Sclerosis Patient Seeks Help of Stem Cells
6. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
7. Human Chain Seeks AIIMS Status For Tiruchi Medical College
8. Harney Seeks Approval for New Medical Practitioners Bill
9. Drug Company Seeks Approval for Human Testing of Vaccine against H5N1 Virus
10. BJP Seeks Tougher Laws Against Pre-Natal Sex Tests
11. Valiathan Committee Seeks Documents from AIIMS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: